Literature DB >> 1608962

Zinc regulates the function of two superantigens.

J D Fraser1, R G Urban, J L Strominger, H Robinson.   

Abstract

Staphylococcal enterotoxins bind with high affinity to class II major histocompatibility complex proteins and subsequently stimulate large numbers of T cells via the V beta portion of the T-cell receptor. Binding of enterotoxin A and enterotoxin E to HLA-DR was completely abolished by low levels of EDTA, whereas binding of toxic shock toxin was unaffected. Addition of Zn2+ to as little as 2 microM excess over EDTA completely reconstituted binding, but Ca2+, Mg2+, Cu2+, Fe2+, and Mn2+ had no effect. The dissociation constant (Kd) of 65Zn2+ binding to a single site on purified enterotoxin A was 2 microM, and addition of purified HLA-DR1 did not alter the Kd, indicating that the binding site was exclusive to enterotoxin A. In the presence of saturating levels of zinc the Kd for enterotoxin A binding to purified HLA-DR1 was 25 nM. Thus, zinc binding is an essential first step in the formation of the major histocompatibility complex binding domain of at least two bacterial superantigens. Given the measured Kd of zinc binding to enterotoxin A, serum levels of free zinc (0.2-1.0 microM) may well regulate the toxic sequelae by these two superantigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608962      PMCID: PMC49321          DOI: 10.1073/pnas.89.12.5507

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.

Authors:  J A Mollick; R G Cook; R R Rich
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

Review 2.  T-cell responses to Mls and to bacterial proteins that mimic its behavior.

Authors:  C A Janeway; J Yagi; P J Conrad; M E Katz; B Jones; S Vroegop; S Buxser
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

3.  Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.

Authors:  N R Gascoigne; K T Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

4.  Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.

Authors:  H Fischer; M Dohlsten; M Lindvall; H O Sjögren; R Carlsson
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

5.  Superantigens interact with MHC class II molecules outside of the antigen groove.

Authors:  P Dellabona; J Peccoud; J Kappler; P Marrack; C Benoist; D Mathis
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

6.  Inactivation of staphylococcal enterotoxin A by chemical modification.

Authors:  G N Stelma; M S Bergdoll
Journal:  Biochem Biophys Res Commun       Date:  1982-03-15       Impact factor: 3.575

Review 7.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.

Authors:  Y Choi; J W Kappler; P Marrack
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

9.  Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus.

Authors:  H Acha-Orbea; A N Shakhov; L Scarpellino; E Kolb; V Müller; A Vessaz-Shaw; R Fuchs; K Blöchlinger; P Rollini; J Billotte
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

10.  Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen.

Authors:  C L Atkin; B C Cole; G J Sullivan; L R Washburn; B B Wiley
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

View more
  24 in total

1.  Mapping of staphylococcal enterotoxin A functional binding sites and presentation by monoclonal antibodies and fusion proteins.

Authors:  W Mahana
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence.

Authors:  K Petersson; M Håkansson; H Nilsson; G Forsberg; L A Svensson; A Liljas; B Walse
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Functional analysis of Mycoplasma arthritidis-derived mitogen interactions with class II molecules.

Authors:  C Bernatchez; R Al-Daccak; P E Mayer; K Mehindate; L Rink; S Mecheri; W Mourad
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 4.  Genetically engineered superantigens in experimental tumor therapy.

Authors:  P Antonsson; J Hansson; T Kalland; P A Lando; L Ohlsson; E Schad; A Svensson; M Dohlsten
Journal:  Springer Semin Immunopathol       Date:  1996

Review 5.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Zinc regulates cytokine induction by superantigens and lipopolysaccharide.

Authors:  C Driessen; K Hirv; H Kirchner; L Rink
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

7.  Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions.

Authors:  T O Harris; M J Betley
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A.

Authors:  U F Hartwig; D Gerlach; B Fleischer
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

9.  Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster.

Authors:  C A Earhart; G M Vath; M Roggiani; P M Schlievert; D H Ohlendorf
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

10.  Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A.

Authors:  M Hoffman; M Tremaine; J Mansfield; M Betley
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.